CLEAR CELL CARCINOMA OF THE OVARY
Clinical trials for CLEAR CELL CARCINOMA OF THE OVARY explained in plain language.
Never miss a new study
Get alerted when new CLEAR CELL CARCINOMA OF THE OVARY trials appear
Sign up with your email to follow new studies for CLEAR CELL CARCINOMA OF THE OVARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug lorigerlimab takes on Platinum-Resistant ovarian cancer
Disease control Recruiting nowThis phase 2 trial is testing a drug called lorigerlimab in about 80 people with advanced ovarian or clear cell gynecologic cancers that have stopped responding to platinum chemotherapy. Lorigerlimab is a bispecific antibody designed to activate the immune system against tumors. …
Matched conditions: CLEAR CELL CARCINOMA OF THE OVARY
Phase: PHASE2 • Sponsor: MacroGenics • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New hope for rare ovarian cancer: immunotherapy combo tested in phase II trial
Disease control Recruiting nowThis phase II trial is testing whether the immunotherapy drug dostarlimab, alone or combined with bevacizumab, can control recurrent gynecological clear cell carcinoma better than standard chemotherapy. About 198 women with this rare cancer type will be randomly assigned to one o…
Matched conditions: CLEAR CELL CARCINOMA OF THE OVARY
Phase: PHASE2 • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could 3 chemo rounds be enough? new trial aims to cut treatment burden
Disease control Recruiting nowThis study tests whether women with advanced ovarian cancer who have had all visible tumor removed can safely receive only 3 cycles of chemotherapy instead of the standard 6, followed by a maintenance drug called niraparib. The goal is to see if the shorter chemo is just as effec…
Matched conditions: CLEAR CELL CARCINOMA OF THE OVARY
Phase: PHASE2 • Sponsor: North Eastern German Society of Gynaecological Oncology • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New hope for rare ovarian cancer? drug trial targets Hard-to-Treat clear cell tumors
Disease control Recruiting nowThis study tests a drug called belzutifan in people with a rare, hard-to-treat type of gynecologic cancer called clear cell carcinoma. The goal is to see if the drug can shrink tumors or stop them from growing. About 32 participants will receive the drug, and researchers will mon…
Matched conditions: CLEAR CELL CARCINOMA OF THE OVARY
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC